FDA
-
-
-
-
-
-
-
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on GRAIL, Inc. (GRAL)
-
-
-
-
-
-
-
TD Cowen Starts GRAIL, Inc. (GRAL) at Hold
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) PT Raised to $85 at Canaccord Genuity
-
-
-
-
-
-
-
GRAIL to present data from 32,000 participants at medical conferences
-
-
-
-
-
-
-
GRAIL (GRAL) and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's GalleriĀ® Multi-Cancer Early Detection (MCED) Test
-
-
-
-
-
-
-
Morgan Stanley Starts GRAIL, Inc. (GRAL) at Equalweight
-
322,966 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

